Zai Lab Limited (ZLAB) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Zai Lab Limited  (NASDAQ: ZLAB)
 

Zai Lab Limited Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZLAB Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -6.46 % 12.22 % 8.96 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) -21.93 % -2.93 % -5.51 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 8.36 % 9.25 % 8.62 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) -1.49 % 2.69 % 2.02 % 2.61 %
Revenue 5 Year Average Growth 56.54 % 8.75 % 9.34 % 13.48 %


ZLAB's Growth Comparisons in I. Quarter 2026




Although the Major Pharmaceutical Preparations industry saw advancing Revenue by 12.22%, Zai Lab Limited announced -6.46% year on year sales decline in the first quarter 2026, to $ 100 millions, and underperformed the 8.96% Revenue growth in the Healthcare sector. Comparing the first quarter, sales Zai Lab Limited was trailing overall market not just Major Pharmaceutical Preparations industry.

Comparing company's Revenue to the fourth quarter results, sales were lower by -21.93% . On the annual basis, average annual sales growth for Zai Lab Limited is 56.54%, while S & P 500's including only Businesses with the first quarter 2026 results, average yearly sales growth is 13.48% over the past five years.

ZLAB Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
ZEJULA
-39.5 %
-
VYVGART VYVGART Hytrulo
-3.06 %
-
NUZYRA
7.57 %
-
OPTUNE
6.22 %
-
QINLOCK
5.59 %
-
XACDURO
667.41 %
-
AUGTYRO
10.21 %
-
Other
26.15 %
-
Total
-6.46 %
-78.35 %


Growth Rates of ZLAB's Income in the first quarter 2026


ZLAB Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - -8.88 % 4.74 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) - -4.52 % 1.4 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) - 30.63 % 30.7 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) - -2.27 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change - 14.98 % 10.62 % 28.66 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - -34.9 % -26.28 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - -2.61 % -66.2 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 6.3 % 2.7 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - -10.02 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 14.8 % 8.95 % -24.17 %

ZLAB Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - -35.09 % -26.24 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) - 2.87 % -1.54 % 27.07 %
Y / Y Net Income Change (Q1 TTM) - 5.27 % 15.53 % 57.33 %
Sequential Net Income Change (Q1 TTM) - -10.16 % -6.71 % 18.65 %
Net Income 5 Year Avg. Growth - 14.99 % 9.41 % 30.75 %

ZLAB's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - -40.27 % -26.28 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - -7.72 % -66.2 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - 2.03 % 8.95 % -24.17 %



ZLAB EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - -40.45 % -26.24 % -24.17 %
Q / Q EPS Net Growth (Q1 MRQ) - -2.53 % -1.54 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - - - 4.93 %
EPS Net 5 Year Avg. Change - 14.99 % 9.41 % 30.75 %



Zai Lab Limited reported bottom-line of $ -0.46 in the first quarter, compare to $ -0.45 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -40.45%, while Healthcare sector decreased by -26.24%, and overall market improved by 90.69%.

Comparing the company's EPS to the fourth quarter results, income per share were lower by -21.93% . On the annual basis, average annual income per share growth for Zai Lab Limited is 56.54%, while S & P 500's including only Businesses with the first quarter 2026 financial reports, average yearly income per share growth is 30.75% over the past five years.

ZLAB Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - 25.53 % 49.77 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) - -42.37 % -47.19 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) - 12.22 % 18.94 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) - 3.32 % 5.18 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 3.5 % 1.82 % 18.38 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - - -86.74 % 152.64 %
Net Cash Flow 5 Year Avg. Change -8.9 % 29.18 % 6.07 % 4.29 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 476.42 % 11.25 % 8.24 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) 1617.26 % -25.6 % -21.55 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) -39.2 % 18.04 % 8.45 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) 137.24 % 4 % 2.15 % 23.05 %
Capital Expenditures 5 Year Avg. Change - 7.06 % 7.13 % 11.23 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.